J&J drops development of combination arthritis drug-March 2024-www.financetom.com

J&J drops development of combination arthritis drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

J&J drops development of combination arthritis drug

Aug 28, 2025 2:35 PM

Aug 28 (Reuters) - Johnson & Johnson ( JNJ ) said on

Thursday it has decided not to proceed with the development of

its combination drug in patients with a type of arthritis, after

results from a mid-stage trial did not show sufficient benefit.

Previous page： Harris courts union vote with Biden at her side Next page： ADMA Biologics Insider Sold Shares Worth $2,363,932, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Harris courts union vote with Biden at her side

Sep 3, 2024

PITTSBURGH (Reuters) -Democratic presidential candidate Kamala Harris said on Monday that U.S. Steel should remain in domestic hands, making a pitch alongside President Joe Biden to working-class voters in Pennsylvania who are also being courted by her rival. The event on Labor Day, a U.S. holiday that signifies the start of the post-summer sprint to the Nov. 5 election, marked...

ADMA Biologics Insider Sold Shares Worth $2,363,932, According to a Recent SEC Filing

Sep 3, 2024

03:29 AM EDT, 09/03/2024 (MT Newswires) -- Jerrold B Grossman, Director, on August 29, 2024, sold 136,861 shares in ADMA Biologics ( ADMA ) for $2,363,932. Following the Form 4 filing with the SEC, Grossman has control over a total of 560,012 shares of the company, with 467,305 shares held directly and 92,707 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1368514/000114036124039821/xslF345X05/form4.xml Price: 17.40,...

Ares Management Insider Sold Shares Worth $7,049,630, According to a Recent SEC Filing

Sep 3, 2024

03:28 AM EDT, 09/03/2024 (MT Newswires) -- Bennett Rosenthal, Director, Co-Founder & Chairman of Private Equity Group, on August 29, 2024, sold 48,421 shares in Ares Management ( ARES ) for $7,049,630. Following the Form 4 filing with the SEC, Rosenthal has control over a total of 1,206,631 shares of the company, with 1,206,631 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1176948/000162828024039013/xslF345X05/wk-form4_1725067440.xml Price:...

Clearview AI fined by Dutch agency for facial recognition database

Sep 3, 2024

AMSTERDAM, Sept 3 (Reuters) - U.S. facial recognition company Clearview AI has been fined 30.5 million euros ($33.71 million) for building what Dutch data protection watchdog DPA said on Tuesday was an illegal database. DPA also issued an additional order, imposing a penalty of up to 5 million euros on Clearview for non-compliance. Reuters was not immediately able to contact...